Evidence map›Paper›PMID 32524474›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2020

A Microfluidic Culture Platform to Assess Axon Degeneration.

Yu Yong, Christopher Hughes, Christopher Deppmann

Open access · greenAbstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Yu YongDepartment of Biology, University of Virginia, Charlottesville, VA, USA.
Christopher HughesDepartment of Physics and Astronomy, James Madison University, Harrisonburg, VA, USA.
Christopher DeppmannDepartment of Biology, University of Virginia, Charlottesville, VA, USA. deppmann@virginia.edu.
University of Virginia · USJames Madison University · US

Funding

Extrinsic Mechanisms Governing Injury-Induced Axon DegenerationR01NS091617 · NINDS · UNIVERSITY OF VIRGINIA · PI DEPPMANN, CHRISTOPHER D · 2015 to 2025
$4.0M
NINDS NIH HHS R01 NS091617
6 · The paper itself

Abstract

The field of microfluidics allows for the precise spatial manipulation of small amounts of fluids. Within microstructures, laminar flow of fluids can be exploited to control the diffusion of small molecules, creating desired microenvironments for cells. Cellular neuroscience has benefited greatly from devices designed to fluidically isolate cell bodies and axons. Microfluidic devices specialized for neuron compartmentalization are made of polydimethylsiloxane (PDMS) which is gas permeable, is compatible with fluorescence microscopy, and has low cost. These devices are commonly used to study signals initiated exclusively on axons, somatodendritic compartments, or even single synapses. We have also found that microfluidic devices allow for rapid, reproducible interrogation of axon degeneration. Here, we describe the methodology for assessing axonal degeneration in microfluidic devices. We describe several use cases, including enucleation (removal of cell bodies) and trophic deprivation to investigate axon degeneration in pathological and developmental scenarios, respectively.

Indexed as

Lab-On-A-Chip DevicesAnimalsAxonsAxotomyCells, CulturedDimethylpolysiloxanesEquipment DesignImmunohistochemistryIntravital MicroscopyMiceMicrofluidic Analytical TechniquesNerve Growth FactorRandom AllocationReproducibility of ResultsSensory Receptor CellsSingle-Blind MethodbaysilonDimethylpolysiloxanesNerve Growth FactorAxon degenerationInjuryMicrofluidic devicesNGF deprivationPDMSWallerian degeneration

Identifiers

PMID32524474
PMCPMC7597676
OpenAlexW3033086666

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.